Suppression of AMD-Like Pathology by Mitochondria-Targeted Antioxidant SkQ1 Is Associated with a Decrease in the

Natalia A Muraleva1, Oyuna S Kozhevnikova2, Anzhela Z Fursova3

  • 1Institute of Cytology and Genetics SB RAS, Pr. Lavrentyeva 10, Novosibirsk 630090, Russia. Myraleva@bionet.nsc.ru.

Insights

Mitochondria-targeted antioxidant SkQ1 suppressed age-related macular degeneration (AMD) progression in rats by reducing retinal amyloid beta (Aβ) and inhibiting mTOR signaling. SkQ1 may offer a new prevention strategy for maintaining eye health and treating AMD.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Gerontology

Background:

  • Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss.
  • Amyloid beta (Aβ) accumulation, implicated in Alzheimer's disease, is also found in the retina of AMD patients.
  • The precise role of Aβ in AMD pathogenesis and its potential as a therapeutic target are under investigation.

Purpose of the Study:

  • To investigate the potential of SkQ1, a mitochondria-targeted antioxidant, in preventing AMD-like pathology.
  • To explore the molecular mechanisms underlying SkQ1's effects, specifically focusing on Aβ and mTOR signaling in the retina.

Main Methods:

  • Long-term administration of SkQ1 to senescence-accelerated OXYS rats from 1.5 to 22 months of age.
  • Assessment of AMD-like pathology development in the retina.
  • Quantification of amyloid beta (Aβ) levels and measurement of mTOR signaling activity in the retina.

Main Results:

  • SkQ1 treatment significantly suppressed the development of AMD-like pathology in OXYS rats.
  • Retinal Aβ levels were reduced in SkQ1-treated rats compared to controls.
  • SkQ1 administration suppressed mTOR signaling activity in the retina.

Conclusions:

  • Inhibition of mTOR signaling represents a novel mechanism for the prophylactic effects of SkQ1 against AMD.
  • Dietary supplementation with SkQ1 shows promise as a preventative strategy for maintaining eye health.
  • SkQ1 may serve as a potential therapeutic agent for age-related macular degeneration.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.7K
Decreasing Function01:27

Decreasing Function

A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2​ in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
241
Peroxisomes and Mitochondria01:30

Peroxisomes and Mitochondria

Peroxisomes and mitochondria are two important oxygen-utilizing organelles in eukaryotic cells. Mitochondria carry out cellular respiration—the process that converts energy from food into ATP. Peroxisomes carry out a variety of functions, primarily breaking down different substances, such as fatty acids.
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within...
94.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.0K
Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
858